Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis.

Literature DB >> 18256414

Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis.

Allen C Cheng¹, Wirongrong Chierakul, Wipada Chaowagul, Ploenchan Chetchotisakd, Direk Limmathurotsakul, David A B Dance, Sharon J Peacock, Bart J Currie.

Abstract

Melioidosis is an infectious disease endemic to northern Australia and Southeast Asia. In response to clinical confusion regarding the appropriate dose of amoxicillin-clavulanate, we have developed guidelines for the appropriate dosing of this second-line agent. For eradication therapy for melioidosis, we recommend 20/5 mg/kg orally, three times daily.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2008 PMID： 18256414 PMCID： PMC3034162

Source DB: PubMed Journal: Am J Trop Med Hyg ISSN： 0002-9637 Impact factor: 2.345

11 in total

1. The activity of amoxycillin/clavulanic acid against Pseudomonas pseudomallei.

Authors: D A Dance; V Wuthiekanun; W Chaowagul; N J White
Journal: J Antimicrob Chemother Date: 1989-12 Impact factor: 5.790

Review 2. Melioidosis.

Authors: Sharon J Peacock
Journal: Curr Opin Infect Dis Date: 2006-10 Impact factor: 4.915

3. Laboratory exposure to Burkholderia pseudomallei--Los Angeles, California, 2003.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 2004-10-29 Impact factor: 17.586

4. Pyogenic liver abscess caused by Burkholderia pseudomallei in Taiwan.

Authors: Yu-Lin Lee; Susan Shin-Jung Lee; Hung-Chin Tsai; Yao-Shen Chen; Shue-Ren Wann; Chih-Hsiang Kao; Yung-Ching Liu
Journal: J Formos Med Assoc Date: 2006-08 Impact factor: 3.282

Review 5. Melioidosis: epidemiology, pathophysiology, and management.

Authors: Allen C Cheng; Bart J Currie
Journal: Clin Microbiol Rev Date: 2005-04 Impact factor: 26.132

6. Risk factors for recurrent melioidosis in northeast Thailand.

Authors: Direk Limmathurotsakul; Wipada Chaowagul; Wirongrong Chierakul; Kasia Stepniewska; Bina Maharjan; Vanaporn Wuthiekanun; Nicholas J White; Nicholas P J Day; Sharon J Peacock
Journal: Clin Infect Dis Date: 2006-09-01 Impact factor: 9.079

7. Pharmacokinetic and pharmacodynamic assessment of co-amoxiclav in the treatment of melioidosis.

Authors: Wirongrong Chierakul; Jinda Wangboonskul; Thida Singtoroj; Wirichada Pongtavornpinyo; Jennifer M Short; Bina Maharjan; Vanaporn Wuthiekanun; David A B Dance; Prapit Teparrukkul; Niklas Lindegardh; Sharon J Peacock; Nicholas P Day; Wipada Chaowagul; Nicholas J White
Journal: J Antimicrob Chemother Date: 2006-09-26 Impact factor: 5.790

8. Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis.

Authors: Y Suputtamongkol; A Rajchanuwong; W Chaowagul; D A Dance; M D Smith; V Wuthiekanun; A L Walsh; S Pukrittayakamee; N J White
Journal: Clin Infect Dis Date: 1994-11 Impact factor: 9.079

Review 9. Melioidosis.

Authors: N J White
Journal: Lancet Date: 2003-05-17 Impact factor: 79.321

10. A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis.

Authors: A Rajchanuvong; W Chaowagul; Y Suputtamongkol; M D Smith; D A Dance; N J White
Journal: Trans R Soc Trop Med Hyg Date: 1995 Sep-Oct Impact factor: 2.184

13 in total

1. Pediatric suppurative parotitis in Cambodia between 2007 and 2011.

Authors: Nicole Stoesser; Joanna Pocock; Catrin E Moore; Sona Soeng; Hor P Chhat; Poda Sar; Direk Limmathurotsakul; Nicholas Day; Vann Thy; Vuthy Sar; Christopher M Parry
Journal: Pediatr Infect Dis J Date: 2012-08 Impact factor: 2.129

Review 2. Human Melioidosis.

Authors: I Gassiep; M Armstrong; R Norton
Journal: Clin Microbiol Rev Date: 2020-03-11 Impact factor: 26.132

3. Case Report: Chorioamnionitis and Premature Delivery due to Burkholderia pseudomallei Infection in Pregnancy.

Authors: Michelle C Porter; Craig E Pennell; Patricia Woods; John Dyer; Adam J Merritt; Bart J Currie
Journal: Am J Trop Med Hyg Date: 2018-01-18 Impact factor: 2.345

4. Systemic Melioidosis Presenting as Septic Arthritis.

Authors: Vaishnavi Arunpriyandan; Mayurathan Pakkiyaretnam; Maheswaran Umakanth
Journal: Cureus Date: 2022-05-15

Review 5. Melioidosis.

Authors: W Joost Wiersinga; Harjeet S Virk; Alfredo G Torres; Bart J Currie; Sharon J Peacock; David A B Dance; Direk Limmathurotsakul
Journal: Nat Rev Dis Primers Date: 2018-02-01 Impact factor: 52.329

6. Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial.

Authors: Ploenchan Chetchotisakd; Wirongrong Chierakul; Wipada Chaowagul; Siriluck Anunnatsiri; Kriangsak Phimda; Piroon Mootsikapun; Seksan Chaisuksant; Jiraporn Pilaikul; Bandit Thinkhamrop; Sunchai Phiphitaporn; Wattanachai Susaengrat; Chalongchai Toondee; Surasakdi Wongrattanacheewin; Vanaporn Wuthiekanun; Narisara Chantratita; Janjira Thaipadungpanit; Nicholas P Day; Direk Limmathurotsakul; Sharon J Peacock
Journal: Lancet Date: 2013-11-25 Impact factor: 79.321

Review 7. Treatment and prophylaxis of melioidosis.

Authors: David Dance
Journal: Int J Antimicrob Agents Date: 2014-02-03 Impact factor: 5.283

8. Melioidosis mycotic aneurysm: An uncommon complication of an uncommon disease.

Authors: Philip H Li; Chi Hung Chau; Poon Chuen Wong
Journal: Respir Med Case Rep Date: 2014-12-29

9. Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010.

Authors: Rebecca Lipsitz; Susan Garges; Rosemarie Aurigemma; Prasith Baccam; David D Blaney; Allen C Cheng; Bart J Currie; David Dance; Jay E Gee; Joseph Larsen; Direk Limmathurotsakul; Meredith G Morrow; Robert Norton; Elizabeth O'Mara; Sharon J Peacock; Nicki Pesik; L Paige Rogers; Herbert P Schweizer; Ivo Steinmetz; Gladys Tan; Patrick Tan; W Joost Wiersinga; Vanaporn Wuthiekanun; Theresa L Smith
Journal: Emerg Infect Dis Date: 2012-12 Impact factor: 6.883

Review 10. The Treatment of Melioidosis.

Authors: Timothy J J Inglis
Journal: Pharmaceuticals (Basel) Date: 2010-04-27